My 11-year-old son Ethan has type 1 diabetes. For the last nine years, he’s used a fast-acting insulin called Novolog to effectively control his blood sugar. While my wife and I had read stories about other people having difficulty getting their insulin prescriptions, it was never a problem we experienced. Then one night, I went to the pharmacy to refill Ethan’s prescription and was told by the pharmacist that Novolog was no longer in our insurers’ formulary, and that Ethan had to switch to another insulin we had never heard of. Although we immediately appealed with our insurer, Ethan’s health quickly deteriorated. His body was rejecting the new insulin, causing him vision loss, nausea, dizziness, weakness, and extremely high blood sugar. My wife and I were taking turns staying up all night to monitor his blood sugar levels, and at one point my 11-year-old son asked me if he was going to die. After 8 days of numerous appeals and physician’s authorizations, our insurer finally reversed their decision, and Ethan is once again taking the insulin he needs to stay alive. But that doesn’t change the fact that we came close to losing our son for no other reason than the greed of our health insurer.